MALVERN, Pa.--(BUSINESS WIRE)--Orthovita, Inc. (NASDAQ: VITA), an orthobiologics and biosurgery company, reported financial results for the quarter ended March 31, 2009. Product sales for the quarter ended March 31, 2009 increased 34% to $21.7 million, as compared to $16.2 million for the same period in 2008.
